Commission welcomes political agreement on Critical Medicines Act

AI-Based Automation for Medication Reconciliation: Scoping Review

The First AI Drug Prescriber

The Burden of Inappropriate Polypharmacy: Approaches to Improve Medication Safety

Factors influencing identification capability of adverse drug reactions in children aged 8–18 years based on social cognitive theory

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

Details of oral anticancer drug prescription audits by community pharmacists: a retrospective analysis of prescription inquiries

Branding en “contextos sensibles”: la seguridad en el packaging farmacéutico en personas mayores a través del análisis de la isoapariencia visual y verbal

Counterfeit Chronicles: Describing and Explicating Online Advertising for Counterfeit Products

BERT-Based Models for Normalization of Adverse Drug Event Expressions in Social Media to Standard Medical Terminology for Drug Safety Analysis

Personalized Dosage System as a Tool for Detecting Adverse Drug Reactions: Pharmaceutical Intervention in a Polymedicated Patient

The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy

Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database

The Role of Electronic Medical Record Systems and Pharmacovigilance Databases in the Surveillance of Antimicrobial Use and Resistance in Low- and Middle-Income Countries: Protocol for a Multistudy Project

Pharmacovigilance analysis and real-world adverse event profile (safety signals and product-related issues) of potassium citrate: a US FDA adverse event reporting system (FAERS) based analysis

Interstitial lung disease associated with novel anticancer agents in non-small cell lung cancer: a pharmacovigilance analysis using the FAERS database

Pharmacovigilance Regulatory Requirements for the Natural Health Products (NHPs) Industry in World Health Organization-Defined High Health Expenditure Countries (2020): A Scoping Review

Antibiotic-associated encephalopathy: A retrospective pharmacovigilance study based on 21 years of data from the US FDA Adverse Event Reporting System

Prescribing trends and spontaneous reporting patterns of adverse drug reactions of ADHD medications in children and adolescents in germany: A retrospective analysis (2013–2022)

Continued Use of Medications Withdrawn Internationally for Safety Concerns: Insights from an Urban Employed Population in China

Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data

FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics

MHRA strengthens safety warnings for finasteride and dutasteride

Inoculation: A Vaccine Against Anti-vaccine Arguments

Combination therapy and its resistance in the development of antimalarial drugs

Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment

Drug Safety for Lactating Women: Still a Forgotten Frontier?

Counterfeit anti-rabies vaccine as a neglected issue: a manufacturers’ perspective

ADHD medications and drug withdrawal: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database

Pharmacovigilance and toxicological studies on safety signals associated with the combined use of propofol and midazolam

Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)

Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methods

Efficacy and Safety of Digitalis Glycosides in Heart Failure. A Meta-Analysis

Precautionary recall of antidepressant medication due to manufacturing error

La OMS rechaza nuevamente la inclusión del metilfenidato para el TDAH en su lista de medicamentos esenciales

Fake Malaria Drugs Undermine Africa’s Fight

Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

La AEMPS adecúa los formatos de antibióticos para alinearlos con las pautas clínicas habituales y evitar su uso inapropiado

New Drugs Are Primary Care Game Changers, but Pricey